Inducible Mutagenesis Vectors for Controlled Mutation Rates

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current in vivo methods for random mutagenesis in cells lack control and efficiency, leading to genomic instability and narrow mutational spectra, which limits the ability to achieve high mutation rates and desired genetic diversity in directed evolution processes.

Innovation Solution

The development of potent, inducible, broad-spectrum mutagenesis systems using recombinant expression constructs that disrupt proof-reading, translesion synthesis, and repair pathways in bacterial cells, allowing for modulation of mutation rates and enhanced mutational spectra through the use of specific gene products and inducible promoters.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If conventional in vivo mutagenesis methods are used, then genetic diversity is generated, but control over mutation rate and spectrum is lost leading to genomic instability

Engineering Contradiction:
Improvecontrol over mutation rateVSAvoidgenomic stability
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent uses inducible promoters (e.g., arabinose-inducible PBAD promoter, tetracycline-inducible promoters) to dynamically control the expression levels of mutagenic genes. By adjusting inducer concentration, the mutation rate can be precisely tuned from basal to high levels, enabling controlled generation of genetic diversity while maintaining genomic stability when induction is absent or low

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent extracts and overexpresses specific mutagenic gene products (dnaQ926 for proofreading disruption, umuD' and umuC for translesion synthesis, recA730 for repair pathway disruption) separately from their native genomic context. This allows selective activation of specific mutagenic pathways without activating all potential mutagenic mechanisms, providing control over mutation spectrum and reducing uncontrolled genomic instability

Inventive Principle:
Principle #2Taking out (Extraction)

2Productivity

If conventional in vivo mutagenesis methods are used, then mutations are generated, but efficiency is low limiting the achievement of high mutation rates

Engineering Contradiction:
Improvemutation rateVSAvoidtime to achieve desired genetic diversity
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The patent combines multiple mutagenic gene products into single expression vectors or co-expression systems. For example, vectors contain combinations of dnaQ926, umuD', umuC, and recA730 genes under the control of inducible promoters, allowing simultaneous activation of multiple mutagenic pathways to achieve synergistic high mutation rates that exceed the sum of individual contributions

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent prepares host cells with pre-installed inducible mutagenesis systems before directed evolution experiments. The mutagenic genes are integrated into the host genome or maintained on stable plasmids with inducible promoters, so that high mutation rates can be immediately activated by adding inducer without requiring time-consuming transformation or cell preparation steps during the evolution process

Inventive Principle:
Principle #10Preliminary action

3Adaptability or versatility

If conventional in vivo mutagenesis methods are used, then some mutations are generated, but the mutational spectrum is narrow

Engineering Contradiction:
Improvemutational spectrumVSAvoidsystem complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent employs a modular vector system where different mutagenic gene combinations can be inserted into standardized expression vectors with inducible promoters. The same basic vector architecture and induction mechanism work across multiple mutagenic gene combinations, allowing broad mutational spectra to be achieved through simple gene assembly rather than complex system redesign. The system has been successfully applied to diverse organisms including E. coli, S. cerevisiae, and mammalian cells

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS11299729B2Vector-based mutagenesis system
Publication Date: 2022.04.12 PRESIDENT & FELLOWS OF HARVARD COLLEGE
  • US11299729B2 patent drawing
  • US11299729B2 patent drawing
  • US11299729B2 patent drawing

AI summary

Strategies, reagents, methods, and systems for modulating the mutation rate in cells are provided herein. The strategies, reagents, methods, and systems are broadly applicable for the modulation of mutation rates in cells where high mutation rates and/or control over a broad range of mutation rates is desired, for example, in the context of diversifying a nucleic acid sequence or a plurality of such sequences within a population of cells, for the generation of diversified nucleic acid libraries, and for directed evolution of nucleic acids and encoded products.